Log in to your Inderes Free account to see all free content on this page.
Nanoform Finland
1.212
EUR
-2.26 %
NANOFH
First North Finland
Medical Equipment & Services
Health Care
3,483 following
-2.26%
+2.19%
-26.01%
-30.1%
-23.53%
-23.77%
-81%
-
-76%
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Read moreMarket cap
103.66M EUR
Turnover
77.58K EUR
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
27.2.
2025
Annual report '24
15.4.
2025
General meeting '24
20.5.
2025
Interim report Q1'25
ShowingAll content types
Nanoform Finland Plc - Manager's Transactions - Peter Hänninen
Nanoform Finland Plc - Manager's Transactions - Edward Hæggström
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio